CR Pharm Operating Revenue from Nutritional Healthcare Products Increased
date：2017-01-25
browse：（800）
Keyword：
CR Pharm Operating Revenue from Nutritional Healthcare Products Increased by 40%
2016 annual performance of CR Pharmaceutical (03320): the company gained HKD156,705 million of revenue with a year-on-year growth of 6.9%; and it saw a 1% year-on-year decrease in net profit which realized HKD2,821 million. Among which, the revenue from nutritional healthcare products reached HKD524 million with a year-on-year growth of 37.1%, mainly due to the increasing market requirement of nutritional healthcare products and the enhancement of terminal promotion.
2016 annual performance of CR Pharmaceutical (03320): the company gained HKD156,705 million of revenue with a year-on-year growth of 6.9%; and it saw a 1% year-on-year decrease in net profit which realized HKD2,821 million. Among which, the revenue from nutritional healthcare products reached HKD524 million with a year-on-year growth of 37.1%, mainly due to the increasing market requirement of nutritional healthcare products and the enhancement of terminal promotion.
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
